Literature DB >> 32489413

Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: A case report and systematic review of the literature.

Nicholas Ivin1, Valentina Della Torre2, Francis Sanders1, Matthew Youngman1.   

Abstract

Carnitine palmitoyltransferase 2 deficiency is an inherited metabolic disorder involving a deficiency in a mitochondrial enzyme necessary for long chain fatty acid oxidation, and therefore decreased utilisation of fatty acids. The adult form of this condition leads to recurrent rhabdomyolysis triggered by exercise, fasting and infection. It is a very rare condition with only a few hundred reported cases worldwide. Here we present a case of severe rhabdomyolysis in the context of carnitine palmitoyltransferase 2 deficiency in which major organ involvement was avoided, and organ support was not needed. This prompted us to perform a systematic review of the existing case reports in the literature to ascertain the most frequent patterns of organ involvement and assess the outcomes that are seen in these patients. Our findings suggest that these patients most frequently develop isolated renal failure, often requiring renal replacement therapy; however, the outcomes following this are very good, supporting the early involvement of intensive care teams. © The Intensive Care Society 2019.

Entities:  

Keywords:  Rhabdomyolysis; carnitine palmitoyltransferase; long chain fatty acids; myoglobinuria; renal failure

Year:  2019        PMID: 32489413      PMCID: PMC7238476          DOI: 10.1177/1751143719889766

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  40 in total

1.  Malony-CoA inhibits the S113L variant of carnitine-palmitoyltransferase II.

Authors:  Leila Motlagh; Ralph Golbik; Wolfgang Sippl; Stephan Zierz
Journal:  Biochim Biophys Acta       Date:  2015-10-23

2.  Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency.

Authors:  Diana Lehmann; Stephan Zierz
Journal:  J Neurol Sci       Date:  2014-02-20       Impact factor: 3.181

3.  Exertional rhabdomyolysis leading to acute kidney injury: when genetic defects are diagnosed in adult life.

Authors:  David Cucchiari; Irene Colombo; Ottavia Amato; Manuel Alfredo Podestà; Francesco Reggiani; Rossella Valentino; Irene Faravelli; Silvia Testolin; Maurizio Moggio; Salvatore Badalamenti
Journal:  CEN Case Rep       Date:  2017-12-12

4.  Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.

Authors:  M Deutsch; D Vassilopoulos; N Sevastos; A Papadimitriou; K Vasiliou; A J Archimandritis
Journal:  Eur J Intern Med       Date:  2008-01-09       Impact factor: 4.487

5.  Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency.

Authors:  T Yasuno; H Kaneoka; T Tokuyasu; J Aoki; S Yoshida; M Takayanagi; A Ohtake; M Kanazawa; A Ogawa; K Tojo; T Saito
Journal:  Clin Genet       Date:  2007-03-19       Impact factor: 4.438

6.  Differences between acylcarnitine profiles in plasma and bloodspots.

Authors:  Monique G M de Sain-van der Velden; Eugene F Diekman; Judith J Jans; Maria van der Ham; Berthil H C M T Prinsen; Gepke Visser; Nanda M Verhoeven-Duif
Journal:  Mol Genet Metab       Date:  2013-04-13       Impact factor: 4.797

7.  Acute renal failure due to carnitine palmitoyltransferase II deficiency.

Authors:  B Uzel; M R Altiparmak; R Ataman; K Serdengeçti
Journal:  Neth J Med       Date:  2003-12       Impact factor: 1.422

8.  A case of CPT deficiency, homoplasmic mtDNA mutation and ragged red fibers at muscle biopsy.

Authors:  Monica Sciacco; Alessandro Prelle; Gigliola Fagiolari; Andreina Bordoni; Marco Crimi; Alessio Di Fonzo; Patrizia Ciscato; Costanza Lamperti; Elisabetta D'Adda; Stefano Jann; Nereo Bresolin; Giacomo P Comi; Maurizio Moggio
Journal:  J Neurol Sci       Date:  2005-09-15       Impact factor: 3.181

Review 9.  De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.

Authors:  Francis W B Sanders; Julian L Griffin
Journal:  Biol Rev Camb Philos Soc       Date:  2015-03-04

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.